Nkarta, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
NKTX Company Description
Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.
NKTX Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view NKTX Smart Score
Score Breakdown
NKTX Company Description
Show More
Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of NKTX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by NKTX's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on NKTX's company Twitter account
WallStreetBets
Number of mentions of NKTX in WallStreetBets Daily Discussion
NKTX News
Recent insights relating to NKTX
CNBC Recommendations
Recent picks made for NKTX stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in NKTX
Corporate Flights
Flights by private jets registered to NKTX
Our Analysis